speb/financial-data huggingface dataset:
QGEN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 423211000.00
QGEN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 423211000.00
QGEN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 423211000.00
QGEN cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -20112000.00
QGEN income_statement (annual, 2022-12-31) — Net Interest Income: -25600000.00
QGEN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -504002000.00
QGEN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -108551000.00
QGEN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -108551000.00
QGEN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -25600000.00
QGEN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -17252000.00
QGEN cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -9774000.00
QGEN balance_sheet (annual, 2022-12-31) — Net PPE: 662170000.00
QGEN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -129224000.00
QGEN cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
QGEN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 569246000.00
QGEN income_statement (annual, 2022-12-31) — Normalized EBITDA: 824123000.00
QGEN income_statement (annual, 2022-12-31) — Normalized Income: 460189368.00
QGEN cash_flow (annual, 2022-12-31) — Operating Cash Flow: 715264000.00
QGEN cash_flow (annual, 2022-12-31) — Operating Gains Losses: 6230000.00
QGEN income_statement (annual, 2022-12-31) — Operating Income: 576228000.00
QGEN income_statement (annual, 2022-12-31) — Operating Revenue: 2141518000.00
QGEN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 204011784.00
QGEN balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 389552000.00
QGEN balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 192194000.00
QGEN balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -404091000.00
QGEN income_statement (annual, 2022-12-31) — Other Gand A: 129725000.00
QGEN income_statement (annual, 2022-12-31) — Other Income Expense: -38027000.00
QGEN balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 544796000.00
QGEN cash_flow (annual, 2022-12-31) — Other Non Cash Items: 56433000.00
QGEN balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 202894000.00
QGEN balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 217985000.00
QGEN income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 6741000.00
QGEN balance_sheet (annual, 2022-12-31) — Other Receivables: 28794000.00
QGEN balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 687597000.00
QGEN balance_sheet (annual, 2022-12-31) — Payables: 112714000.00
QGEN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 301557000.00
QGEN balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
QGEN balance_sheet (annual, 2022-12-31) — Prepaid Assets: 50958000.00
QGEN income_statement (annual, 2022-12-31) — Pretax Income: 512601000.00
QGEN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
QGEN balance_sheet (annual, 2022-12-31) — Properties: 0.00
QGEN cash_flow (annual, 2022-12-31) — Purchase Of Business: -63651000.00
QGEN cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -20112000.00
QGEN cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1387085000.00
QGEN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -129224000.00
QGEN balance_sheet (annual, 2022-12-31) — Raw Materials: 97613000.00
QGEN balance_sheet (annual, 2022-12-31) — Receivables: 434068000.00
QGEN income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 563089000.00
QGEN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 208397000.00
QGEN cash_flow (annual, 2022-12-31) — Repayment Of Debt: -480003000.00
QGEN cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
QGEN income_statement (annual, 2022-12-31) — Research And Development: 189859000.00
QGEN balance_sheet (annual, 2022-12-31) — Restricted Cash: 21083000.00
QGEN income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 44768000.00
QGEN balance_sheet (annual, 2022-12-31) — Retained Earnings: 2160173000.00
QGEN cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
QGEN cash_flow (annual, 2022-12-31) — Sale Of Investment: 883083000.00
QGEN income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 474220000.00
QGEN income_statement (annual, 2022-12-31) — Selling General And Administration: 603945000.00
QGEN balance_sheet (annual, 2022-12-31) — Share Issued: 206800729.00
QGEN cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
QGEN cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
QGEN income_statement (annual, 2022-12-31) — Special Income Charges: -44768000.00
QGEN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 49507000.00
QGEN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3466611000.00
QGEN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 569246000.00
QGEN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -7789632.00
QGEN income_statement (annual, 2022-12-31) — Tax Provision: 89390000.00
QGEN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.17
QGEN balance_sheet (annual, 2022-12-31) — Taxes Receivable: 81524000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Assets: 6287735000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Capitalization: 4938509000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Debt: 1883670000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3466611000.00
QGEN income_statement (annual, 2022-12-31) — Total Expenses: 1565290000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2821124000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3893783000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1846601000.00
QGEN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 531460000.00
QGEN balance_sheet (annual, 2022-12-31) — Total Tax Payable: 13980000.00
QGEN income_statement (annual, 2022-12-31) — Total Unusual Items: -44768000.00
QGEN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -44768000.00
QGEN balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2788945.00
QGEN balance_sheet (annual, 2022-12-31) — Treasury Stock: 160188000.00
QGEN balance_sheet (annual, 2022-12-31) — Work In Process: 85488000.00
QGEN balance_sheet (annual, 2022-12-31) — Working Capital: 1419429000.00
QGEN income_statement (annual, 2023-12-31) — +Operating Expense: 788441000.00
QGEN income_statement (annual, 2023-12-31) — +Total Revenue: 1965311000.00
QGEN balance_sheet (annual, 2023-12-31) — Accounts Payable: 84155000.00
QGEN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 381877000.00
QGEN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -516765000.00
QGEN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1915115000.00
QGEN balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -17296000.00
QGEN income_statement (annual, 2023-12-31) — Amortization: 10764000.00
QGEN income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 10764000.00
QGEN cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 4158000.00
QGEN income_statement (annual, 2023-12-31) — Basic Average Shares: 204447482.00
QGEN income_statement (annual, 2023-12-31) — Basic EPS: 1.67
QGEN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 730669000.00
QGEN balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 382836000.00
QGEN cash_flow (annual, 2023-12-31) — Capital Expenditure: -162802000.00
QGEN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 22268000.00
QGEN balance_sheet (annual, 2023-12-31) — Capital Stock: 2702000.00
QGEN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 668084000.00
QGEN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1057782000.00
QGEN cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
QGEN balance_sheet (annual, 2023-12-31) — Cash Equivalents: 580704000.00
QGEN balance_sheet (annual, 2023-12-31) — Cash Financial: 87380000.00
QGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -433827000.00
QGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -87655000.00
QGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 459455000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Account Payable: -22417000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -55583000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Inventory: -44787000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 691000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -6675000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -7458000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Payable: -22417000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -78000000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 4390000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Receivables: -55119000.00
QGEN cash_flow (annual, 2023-12-31) — Change In Working Capital: -186958000.00
QGEN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -55119000.00
QGEN cash_flow (annual, 2023-12-31) — Changes In Cash: -62027000.00
QGEN balance_sheet (annual, 2023-12-31) — Common Stock: 2702000.00
QGEN cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: 0.00
QGEN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3807764000.00
QGEN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 163000.00
QGEN cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
QGEN balance_sheet (annual, 2023-12-31) — Construction In Progress: 203978000.00
QGEN income_statement (annual, 2023-12-31) — Cost Of Revenue: 731623000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 187960000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Assets: 2147560000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 22268000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Debt: 587970000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 610238000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 66432000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 66432000.00
QGEN balance_sheet (annual, 2023-12-31) — Current Liabilities: 1079293000.00
QGEN cash_flow (annual, 2023-12-31) — Deferred Income Tax: 10731000.00
QGEN cash_flow (annual, 2023-12-31) — Deferred Tax: 10731000.00
QGEN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 205336000.00
QGEN income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 10764000.00
QGEN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 205336000.00
QGEN income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 10764000.00
QGEN balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 98908000.00
QGEN income_statement (annual, 2023-12-31) — Diluted Average Shares: 206612202.00
QGEN income_statement (annual, 2023-12-31) — Diluted EPS: 1.65
QGEN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 341303000.00
QGEN income_statement (annual, 2023-12-31) — EBIT: 483219000.00
QGEN income_statement (annual, 2023-12-31) — EBITDA: 688555000.00
QGEN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -558000.00
QGEN cash_flow (annual, 2023-12-31) — End Cash Position: 668084000.00
QGEN balance_sheet (annual, 2023-12-31) — Financial Assets: 3083000.00
QGEN cash_flow (annual, 2023-12-31) — Financing Cash Flow: -433827000.00
QGEN balance_sheet (annual, 2023-12-31) — Finished Goods: 212445000.00
QGEN cash_flow (annual, 2023-12-31) — Free Cash Flow: 296653000.00
QGEN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -433830000.00
QGEN income_statement (annual, 2023-12-31) — General And Administrative Expense: 119254000.00
QGEN balance_sheet (annual, 2023-12-31) — Goodwill: 2475732000.00
QGEN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3002553000.00
QGEN balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 399173000.00
QGEN balance_sheet (annual, 2023-12-31) — Gross PPE: 1281802000.00
QGEN income_statement (annual, 2023-12-31) — Gross Profit: 1233688000.00
QGEN balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 43230000.00
QGEN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 82409000.00
QGEN balance_sheet (annual, 2023-12-31) — Income Tax Payable: 12475000.00
QGEN income_statement (annual, 2023-12-31) — Interest Expense: 53410000.00
QGEN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 53410000.00
QGEN income_statement (annual, 2023-12-31) — Interest Income: 78992000.00
QGEN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 78992000.00
QGEN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 20348000.00
QGEN balance_sheet (annual, 2023-12-31) — Interest Payable: 8518000.00
QGEN balance_sheet (annual, 2023-12-31) — Inventory: 398385000.00
QGEN balance_sheet (annual, 2023-12-31) — Invested Capital: 5317558000.00
QGEN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -87655000.00
QGEN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 163000.00
QGEN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
QGEN balance_sheet (annual, 2023-12-31) — Land And Improvements: 26239000.00
QGEN balance_sheet (annual, 2023-12-31) — Long Term Debt: 921824000.00
QGEN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 921824000.00
QGEN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
QGEN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -436762000.00
QGEN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 668749000.00
QGEN cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -149532000.00
QGEN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 163000.00
QGEN balance_sheet (annual, 2023-12-31) — Net Debt: 841710000.00
QGEN income_statement (annual, 2023-12-31) — Net Income: 341303000.00
QGEN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 341303000.00
QGEN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 341303000.00
QGEN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 341303000.00
QGEN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 341303000.00
QGEN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 341303000.00
QGEN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 341303000.00
QGEN cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -13092000.00
QGEN income_statement (annual, 2023-12-31) — Net Interest Income: 25582000.00
QGEN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 291233000.00
QGEN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -436762000.00
QGEN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -436762000.00
QGEN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 25582000.00
QGEN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -33827000.00
QGEN cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -66554000.00
QGEN balance_sheet (annual, 2023-12-31) — Net PPE: 765037000.00
QGEN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -149710000.00
QGEN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 805211000.00
QGEN income_statement (annual, 2023-12-31) — Normalized EBITDA: 723864000.00
QGEN income_statement (annual, 2023-12-31) — Normalized Income: 369338346.00
QGEN cash_flow (annual, 2023-12-31) — Operating Cash Flow: 459455000.00
QGEN income_statement (annual, 2023-12-31) — Operating Income: 445247000.00
QGEN income_statement (annual, 2023-12-31) — Operating Revenue: 1965311000.00
QGEN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 204447482.00
QGEN balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 587970000.00
QGEN balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 118033000.00
QGEN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -433830000.00
QGEN income_statement (annual, 2023-12-31) — Other Gand A: 119254000.00
QGEN income_statement (annual, 2023-12-31) — Other Income Expense: -41020000.00
QGEN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 526821000.00
QGEN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 37785000.00
QGEN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 196957000.00
QGEN balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 207401000.00
QGEN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -5711000.00
QGEN balance_sheet (annual, 2023-12-31) — Other Receivables: 53216000.00
QGEN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 389698000.00
QGEN balance_sheet (annual, 2023-12-31) — Payables: 96630000.00
QGEN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 284590000.00
QGEN balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
QGEN balance_sheet (annual, 2023-12-31) — Prepaid Assets: 44854000.00
QGEN income_statement (annual, 2023-12-31) — Pretax Income: 429809000.00
QGEN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 36762000.00
QGEN balance_sheet (annual, 2023-12-31) — Properties: 0.00
QGEN cash_flow (annual, 2023-12-31) — Purchase Of Business: -149532000.00
QGEN cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -13092000.00
QGEN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -979318000.00
QGEN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -149710000.00
QGEN balance_sheet (annual, 2023-12-31) — Raw Materials: 91204000.00
QGEN balance_sheet (annual, 2023-12-31) — Receivables: 515643000.00
QGEN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 537051000.00
QGEN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 205336000.00
QGEN cash_flow (annual, 2023-12-31) — Repayment Of Debt: -436762000.00
QGEN cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
QGEN income_statement (annual, 2023-12-31) — Research And Development: 198511000.00
QGEN balance_sheet (annual, 2023-12-31) — Restricted Cash: 87666000.00
QGEN income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 35309000.00
QGEN balance_sheet (annual, 2023-12-31) — Retained Earnings: 2456800000.00
QGEN cash_flow (annual, 2023-12-31) — Sale Of Investment: 1270551000.00
QGEN income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 459912000.00
QGEN income_statement (annual, 2023-12-31) — Selling General And Administration: 579166000.00
QGEN balance_sheet (annual, 2023-12-31) — Share Issued: 206800579.00
QGEN income_statement (annual, 2023-12-31) — Special Income Charges: -35309000.00
QGEN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 47100000.00
QGEN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3807764000.00
QGEN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 805211000.00
QGEN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -7273654.00
QGEN income_statement (annual, 2023-12-31) — Tax Provision: 88506000.00
QGEN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
QGEN balance_sheet (annual, 2023-12-31) — Taxes Receivable: 80550000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Assets: 6115190000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Capitalization: 4729588000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Debt: 1532062000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3807764000.00
QGEN income_statement (annual, 2023-12-31) — Total Expenses: 1520064000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2307426000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3967630000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1228133000.00
QGEN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 409938000.00
QGEN balance_sheet (annual, 2023-12-31) — Total Tax Payable: 12475000.00
QGEN income_statement (annual, 2023-12-31) — Total Unusual Items: -35309000.00
QGEN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -35309000.00
QGEN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 2353097.00
QGEN balance_sheet (annual, 2023-12-31) — Treasury Stock: 133023000.00
QGEN balance_sheet (annual, 2023-12-31) — Work In Process: 94736000.00
QGEN balance_sheet (annual, 2023-12-31) — Working Capital: 1068267000.00
QGEN cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
QGEN cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
QGEN balance_sheet (quarterly, 2024-09-30) — Current Debt: 555257000.00
QGEN balance_sheet (quarterly, 2024-09-30) — Derivative Product Liabilities: 0.00
QGEN balance_sheet (quarterly, 2024-09-30) — Financial Assets: 0.00
QGEN balance_sheet (quarterly, 2024-09-30) — Hedging Assets Current: 23835000.00
QGEN balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 19300000.00
QGEN cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
QGEN cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
QGEN balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 14700000.00
QGEN cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
QGEN cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
QGEN cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 496352000.00
QGEN cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 496352000.00
QGEN balance_sheet (quarterly, 2024-09-30) — Non Current Accrued Expenses: 247051000.00
QGEN balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 282594000.00
QGEN balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 555257000.00
QGEN balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 117363000.00
QGEN balance_sheet (quarterly, 2024-09-30) — Other Investments: 4600000.00
QGEN cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
QGEN cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
QGEN cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
QGEN income_statement (annual, 2024-12-31) — +Operating Expense: 767451000.00
QGEN income_statement (annual, 2024-12-31) — +Total Revenue: 1978214000.00
QGEN balance_sheet (annual, 2024-12-31) — Accounts Payable: 83272000.00
QGEN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 349278000.00
QGEN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -516324000.00
QGEN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1666070000.00
QGEN balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -18226000.00
QGEN income_statement (annual, 2024-12-31) — Amortization: 9596000.00
QGEN income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 9596000.00
QGEN cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 203408000.00
QGEN income_statement (annual, 2024-12-31) — Basic Average Shares: 205309513.00
QGEN income_statement (annual, 2024-12-31) — Basic EPS: 0.41
QGEN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 668084000.00
QGEN balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 381506000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 381506000.00
QGEN cash_flow (annual, 2024-12-31) — Capital Expenditure: -171242000.00
QGEN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 120993000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 120993000.00
QGEN balance_sheet (annual, 2024-12-31) — Capital Stock: 2601000.00
QGEN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 663555000.00
QGEN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1152992000.00
QGEN cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
QGEN balance_sheet (annual, 2024-12-31) — Cash Equivalents: 570850000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 570850000.00
QGEN balance_sheet (annual, 2024-12-31) — Cash Financial: 92705000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Cash Financial: 92705000.00
QGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -422896000.00
QGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -249229000.00
QGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 673551000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Account Payable: 1446000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -8642000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Inventory: 87755000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -1194000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 4108000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 25528000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Payable: 1446000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -7196000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 14234000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Receivables: 12218000.00
QGEN cash_flow (annual, 2024-12-31) — Change In Working Capital: 135453000.00
QGEN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 12218000.00
QGEN cash_flow (annual, 2024-12-31) — Changes In Cash: 1426000.00
QGEN balance_sheet (annual, 2024-12-31) — Common Stock: 2601000.00
QGEN cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: 0.00
QGEN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3567339000.00
QGEN cash_flow (annual, 2024-12-31) — Common Stock Payments: -292099000.00
QGEN balance_sheet (annual, 2024-12-31) — Construction In Progress: 226155000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 226155000.00
QGEN income_statement (annual, 2024-12-31) — Cost Of Revenue: 1010864000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 173554000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Assets: 1959853000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 24335000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 24335000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Debt: 551883000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Current Debt: 551883000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 576218000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 576218000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 70827000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 70827000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 70827000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 70827000.00
QGEN balance_sheet (annual, 2024-12-31) — Current Liabilities: 1042031000.00
QGEN cash_flow (annual, 2024-12-31) — Deferred Income Tax: -23041000.00
QGEN cash_flow (annual, 2024-12-31) — Deferred Tax: -23041000.00
QGEN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 203268000.00
QGEN income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 9596000.00
QGEN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 203268000.00
QGEN income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 9596000.00
QGEN balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
QGEN balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
QGEN income_statement (annual, 2024-12-31) — Diluted Average Shares: 207551118.00
QGEN income_statement (annual, 2024-12-31) — Diluted EPS: 0.40
QGEN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 83591000.00
QGEN income_statement (annual, 2024-12-31) — EBIT: 164988000.00
QGEN income_statement (annual, 2024-12-31) — EBITDA: 368256000.00
QGEN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -5955000.00
QGEN cash_flow (annual, 2024-12-31) — End Cash Position: 663555000.00
QGEN balance_sheet (annual, 2024-12-31) — Financial Assets: 3174000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Financial Assets: 3174000.00
QGEN cash_flow (annual, 2024-12-31) — Financing Cash Flow: -422896000.00
QGEN balance_sheet (annual, 2024-12-31) — Finished Goods: 153811000.00
QGEN cash_flow (annual, 2024-12-31) — Free Cash Flow: 502309000.00
QGEN cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 426000.00
QGEN cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 84000.00
QGEN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -474539000.00
QGEN income_statement (annual, 2024-12-31) — General And Administrative Expense: 113432000.00
QGEN balance_sheet (annual, 2024-12-31) — Goodwill: 2425418000.00
QGEN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2729233000.00
QGEN balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 367504000.00
QGEN balance_sheet (annual, 2024-12-31) — Gross PPE: 1269935000.00
QGEN income_statement (annual, 2024-12-31) — Gross Profit: 967350000.00
QGEN balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 23604000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 23604000.00
QGEN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 15684000.00
QGEN balance_sheet (annual, 2024-12-31) — Income Tax Payable: 24946000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 24946000.00
QGEN income_statement (annual, 2024-12-31) — Interest Expense: 43841000.00
QGEN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 43841000.00
QGEN income_statement (annual, 2024-12-31) — Interest Income: 68016000.00
QGEN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 68016000.00
QGEN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 24181000.00
QGEN balance_sheet (annual, 2024-12-31) — Interest Payable: 10554000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Interest Payable: 10554000.00
QGEN balance_sheet (annual, 2024-12-31) — Inventory: 279256000.00
QGEN balance_sheet (annual, 2024-12-31) — Invested Capital: 4958887000.00
QGEN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -249229000.00
QGEN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 494211000.00
QGEN cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: -2141000.00
QGEN balance_sheet (annual, 2024-12-31) — Land And Improvements: 24937000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 24937000.00
QGEN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 96658000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 96658000.00
QGEN balance_sheet (annual, 2024-12-31) — Long Term Debt: 839665000.00
QGEN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 936323000.00
QGEN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 494211000.00
QGEN cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: -2141000.00
QGEN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -601536000.00
QGEN cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -500000000.00
QGEN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 637337000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 637337000.00
QGEN cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
QGEN cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
QGEN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -292099000.00
QGEN cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -292099000.00
QGEN balance_sheet (annual, 2024-12-31) — Net Debt: 727993000.00
QGEN income_statement (annual, 2024-12-31) — Net Income: 83591000.00
QGEN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 83591000.00
QGEN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 83591000.00
QGEN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 83591000.00
QGEN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 83591000.00
QGEN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 83591000.00
QGEN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 83591000.00
QGEN cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -4068000.00
QGEN income_statement (annual, 2024-12-31) — Net Interest Income: 24175000.00
QGEN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -103401000.00
QGEN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -107325000.00
QGEN cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -502141000.00
QGEN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -107325000.00
QGEN cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -502141000.00
QGEN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 24175000.00
QGEN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -315571000.00
QGEN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 25414000.00
QGEN balance_sheet (annual, 2024-12-31) — Net PPE: 753611000.00
QGEN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -167174000.00
QGEN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 838106000.00
QGEN income_statement (annual, 2024-12-31) — Normalized EBITDA: 470444000.00
QGEN income_statement (annual, 2024-12-31) — Normalized Income: 154100720.00
QGEN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 673551000.00
QGEN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 426000.00
QGEN cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 84000.00
QGEN income_statement (annual, 2024-12-31) — Operating Income: 199899000.00
QGEN income_statement (annual, 2024-12-31) — Operating Revenue: 1978214000.00
QGEN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 205309513.00
QGEN balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 551883000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 551883000.00
QGEN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 113214000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 113214000.00
QGEN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -474539000.00
QGEN income_statement (annual, 2024-12-31) — Other Gand A: 113432000.00
QGEN income_statement (annual, 2024-12-31) — Other Income Expense: -102927000.00
QGEN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 303815000.00
QGEN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 26819000.00
QGEN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 246925000.00
QGEN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 143929000.00
QGEN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -739000.00
QGEN balance_sheet (annual, 2024-12-31) — Other Receivables: 45851000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Other Receivables: 45851000.00
QGEN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 489437000.00
QGEN balance_sheet (annual, 2024-12-31) — Payables: 108218000.00
QGEN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 281772000.00
QGEN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
QGEN balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
QGEN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 41772000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 41772000.00
QGEN income_statement (annual, 2024-12-31) — Pretax Income: 121147000.00
QGEN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
QGEN cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
QGEN balance_sheet (annual, 2024-12-31) — Properties: 0.00
QGEN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
QGEN cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
QGEN cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
QGEN cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -4068000.00
QGEN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -688380000.00
QGEN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -167174000.00
QGEN balance_sheet (annual, 2024-12-31) — Raw Materials: 52770000.00
QGEN balance_sheet (annual, 2024-12-31) — Receivables: 458983000.00
QGEN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 817192000.00
QGEN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 203268000.00
QGEN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -601536000.00
QGEN cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -500000000.00
QGEN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -292099000.00
QGEN income_statement (annual, 2024-12-31) — Research And Development: 193494000.00
QGEN balance_sheet (annual, 2024-12-31) — Restricted Cash: 3246000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 3246000.00
QGEN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 102188000.00
QGEN balance_sheet (annual, 2024-12-31) — Retained Earnings: 2448122000.00
QGEN cash_flow (annual, 2024-12-31) — Sale Of Investment: 584979000.00
QGEN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 450929000.00
QGEN income_statement (annual, 2024-12-31) — Selling General And Administration: 564361000.00
QGEN balance_sheet (annual, 2024-12-31) — Share Issued: 206800221.00
QGEN income_statement (annual, 2024-12-31) — Special Income Charges: -102188000.00
QGEN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 43627000.00
QGEN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3567339000.00
QGEN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 838106000.00
QGEN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -31678280.00
QGEN income_statement (annual, 2024-12-31) — Tax Provision: 37556000.00
QGEN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.31
QGEN balance_sheet (annual, 2024-12-31) — Taxes Receivable: 63854000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 63854000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Assets: 5689622000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Capitalization: 4407004000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Debt: 1512541000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3567339000.00
QGEN income_statement (annual, 2024-12-31) — Total Expenses: 1778315000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2122283000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3729769000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1080252000.00
QGEN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 97711000.00
QGEN balance_sheet (annual, 2024-12-31) — Total Tax Payable: 24946000.00
QGEN balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 24946000.00
QGEN income_statement (annual, 2024-12-31) — Total Unusual Items: -102188000.00
QGEN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -102188000.00
QGEN balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 1490708.00
QGEN balance_sheet (annual, 2024-12-31) — Treasury Stock: 74915000.00
QGEN balance_sheet (annual, 2024-12-31) — Work In Process: 72675000.00
QGEN balance_sheet (annual, 2024-12-31) — Working Capital: 917822000.00
QGEN income_statement (quarterly, 2025-03-31) — +Operating Expense: 183518000.00
QGEN income_statement (quarterly, 2025-03-31) — +Total Revenue: 483456000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 69666000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 340706000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -549029000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1398256000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -21124000.00
QGEN income_statement (quarterly, 2025-03-31) — Amortization: 1793000.00
QGEN income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 1793000.00
QGEN cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 2537000.00
QGEN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 218377000.00
QGEN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.42
QGEN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 663555000.00
QGEN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -44264000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 638756000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 963445000.00
QGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -286704000.00
QGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 120081000.00
QGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 139740000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -5968000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -38860000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Inventory: 2171000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 713000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 601000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 28993000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Payable: -5968000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -44828000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -15201000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 12948000.00
QGEN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -14603000.00
QGEN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 12948000.00
QGEN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -26883000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Common Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3407877000.00
QGEN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 174775000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 387867000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Current Assets: 1742871000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Current Debt: 55693000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 55693000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 516944000.00
QGEN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -542000.00
QGEN cash_flow (quarterly, 2025-03-31) — Deferred Tax: -542000.00
QGEN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 43908000.00
QGEN income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 1793000.00
QGEN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 43908000.00
QGEN income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1793000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 409000.00
QGEN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 220189000.00
QGEN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.41
QGEN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 90758000.00
QGEN income_statement (quarterly, 2025-03-31) — EBIT: 126843000.00
QGEN income_statement (quarterly, 2025-03-31) — EBITDA: 170751000.00
QGEN income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -100000.00
QGEN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 2084000.00
QGEN cash_flow (quarterly, 2025-03-31) — End Cash Position: 638756000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Financial Assets: 0.00
QGEN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -286704000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Finished Goods: 152479000.00
QGEN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 95476000.00
QGEN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 968000.00
QGEN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -1300000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -441646000.00
QGEN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 31608000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Goodwill: 2448647000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2739150000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 361830000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1352690000.00
QGEN income_statement (quarterly, 2025-03-31) — Gross Profit: 308681000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 13164000.00
QGEN income_statement (quarterly, 2025-03-31) — Interest Expense: 7294000.00
QGEN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 7294000.00
QGEN income_statement (quarterly, 2025-03-31) — Interest Income: 15390000.00
QGEN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 15390000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Inventory: 281364000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4816216000.00
QGEN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 120081000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1352646000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1352646000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Net Debt: 769583000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Income: 90758000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 90758000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 90758000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 90758000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 90758000.00
QGEN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 90758000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 90758000.00
QGEN cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -362000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Interest Income: 8096000.00
QGEN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 163419000.00
QGEN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 8096000.00
QGEN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -286704000.00
QGEN cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 926000.00